Home
Cancer Clinical Trials
33
NF1 Mutation
Cancer Clinical Trials
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma
Venetoclax, Busulfan, Cladribine, and Fludarabine for the Treatment of High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer
CRAFT: The NCT-PMO-1602 Phase II Trial
Safety and Efficacy Study of SAR442720 in Combination With Pembrolizumab in Advanced Malignancies
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Study of ASTX029 in Subjects With Advanced Solid Tumors
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.